Literature DB >> 21516049

Permanent axial length change as a result of cavernous hemangioma.

Michael J Simpson1, Mark A Alford.   

Abstract

PURPOSE: To describe the visual and physical effects created by a cavernous hemangioma in the orbit of the eye, covering a period of 17 years. CASE REPORT: A 35-year-old white male reported a small blurry spot in the superior visual field of one eye. This had no obvious cause, but eventually after 9 years, the eye was obviously proptotic, and a cavernous hemangioma measuring 36 mm in the longest dimension was removed from the orbit. A retrospective evaluation of spectacle prescriptions found that the refractive error had reduced by 2 D over that time period. The refraction did not undergo any clinically meaningful change after tumor removal, or over the next 8 years. A postoperative measurement of axial lengths found that the eye compressed by the tumor was nearly 1 mm shorter than the fellow eye.
CONCLUSIONS: A cavernous hemangioma in the orbit apparently shortened the axial length of the eye over a period of several years, causing a gradual difference in refraction compared with the fellow eye. The axial length did not change after tumor removal.
Copyright © 2011 American Academy of Optometry

Entities:  

Mesh:

Year:  2011        PMID: 21516049     DOI: 10.1097/OPX.0b013e318219d278

Source DB:  PubMed          Journal:  Optom Vis Sci        ISSN: 1040-5488            Impact factor:   1.973


  2 in total

1.  Post-operative optical coherence tomography angiography features of chorioretinal folds resulting from pleomorphic adenoma of the lacrimal gland (PALG) of orbit- a case report.

Authors:  Nan-Ni Chen; Chien-Hsiung Lai; Tsai Yueh-Ju; Chau -Yin Chen
Journal:  BMC Ophthalmol       Date:  2020-12-10       Impact factor: 2.209

2.  Long term follow-up of persistent choroidal folds and hyperopic shift after complete removal of a retrobulbar mass.

Authors:  Agnes Galbo Jacobsen; Peter Bjerre Toft; Jan Ulrik Prause; Henrik Vorum; János Hargitai
Journal:  BMC Res Notes       Date:  2015-11-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.